Evidence map›Paper›PMID 26034582›Full record

ArticleAntimicrobial resistance and infection control2015

The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.

Jason A Trubiano, Vivian K Leung, Man Y Chu, Leon J Worth, Monica A Slavin, Karin A Thursky

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of beta-lactam allergy labels on bone marrow transplant patients.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  4. Antibiotic use and financial impact of a comprehensive beta-lactam allergy management program.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  5. Article
  6. Patient-related factors impact the implementation of inpatient antibiotic allergy delabeling.The journal of allergy and clinical immunology. Global · 2024
    Article
  7. A call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions.Transplant infectious disease : an official journal of the Transplantation Society · 2024
    Review
  8. Penicillin allergy evaluation in hospitalized patients with hematologic malignancy.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  9. Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Article
  10. Review
  11. Review
  12. It's a rash: Antibiotic allergies in the modern era of antibiotic stewardship.International journal of pediatric otorhinolaryngology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Antibiotic allergy.Lancet (London, England) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jason A TrubianoDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC Australia ; Department of Infectious Diseases, Austin Health, East Melbourne, VIC Australia.
Vivian K LeungDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC Australia.
Man Y ChuDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC Australia.
Leon J WorthDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC Australia.
Monica A SlavinDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC Australia ; Victorian Infectious Diseases Service, Peter Doherty Institute, Melbourne, Australia.
Karin A ThurskyDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC Australia ; Victorian Infectious Diseases Service, Peter Doherty Institute, Melbourne, Australia.
Peter MacCallum Cancer Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntibiotic allergy labels are associated with sub-optimal prescribing patterns and poorer clinical outcomes in non-cancer populations, but the effect of labelling on antimicrobial usage in patients with cancer is unknown.

findingsA retrospective review of hospitalized patients admitted to the Peter MacCallum Cancer Centre (2010-2012) identified 23 % of cancer patients (n = 198) with an antimicrobial allergy label (AA). Comparison of those with an antimicrobial allergy label to those without demonstrated increased antibiotic use per admission (3 vs. 2, p = 0.01), increased fluoroquinolone use (11 % vs. 6 %, p < 0.05), increased antibiotic course duration (15 vs. 13 days, p = 0.09), higher readmission rates (53 % vs. 28 %, p < 0.001) and poorer concordance with prescribing guidelines (47 % vs. 91 %, p < 0.001). Patients in the AA group on multivariate analysis had a higher number of antibiotics employed, longer duration of antibiotic therapy and higher rate of readmission.

conclusionsAntimicrobial usage, including the use of restricted antibiotics, is higher in patients with cancer. Antibiotic de-labelling strategies in cancer patients must be evaluated to aid antimicrobial stewardship initiatives.

Indexed as

Antibiotic allergyAntimicrobial resistanceCancerStewardship

Identifiers

PMID26034582
PMCPMC4450507
OpenAlexW1489456801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.